Showing the latest 10 filings. Sign in to filter or browse the full history. View full history
Showing 10 of 81 filings.
10 Aug 2026 1 filing
Nasense Labs stake divestment
NACL executed a Share Purchase Agreement on August 10, 2026 to divest its Nasense Labs stake.
Nasense Labs Private Limited is an Associate Company of NACL.
Intimation under Regulation 30 of SEBI LODR informed the exchange about the SPA execution.
No monetary consideration or stake details disclosed in the filing.
27 Jul 2026 1 filing
Issue Overview
Rights issue of Equity Shares.
Total issue size and net proceeds reported; no revision or undersubscription.
Main objectives: debt repayment/prepayment.
Investment in subsidiary for debt repayment.
General corporate purposes including capex and working capital.
Issue expenses.
Utilisation of Proceeds
Utilisation as per offer document: Yes; no deviation.
Deviation: General Corporate Purpose shows delay; remaining funds to be utilised later.
Debt repayment: fully utilised.
Investment in subsidiary: fully utilised.
General Corporate Purpose: partially utilised; board approved allocation.
Issue expenses: fully utilised.
Unutilised funds for GCP parked in fixed deposits.
Balance in monitoring account not material; interest earned reflects idle funds.
Governance and Compliance
Approvals: no shareholder approvals required; no pending statutory approvals.
Material events: none reported.
Board approval for GCP allocation obtained.
No other material information.
GCP
GCP utilised for capital expenditure.
Board approval obtained for GCP allocation.
GCP utilisation within cap of gross proceeds.
15 Jul 2026 1 filing
Meeting Details
Board meeting scheduled for Wednesday, July 22, 2026. Time and venue not disclosed.
Key Agenda Items
Consider unaudited standalone and consolidated results for quarter ended June 30, 2026.
Other Notes
Trading window closed from July 1, 2026 to July 24, 2026, 48 hours after results declaration.
14 Jul 2026 1 filing
Dematerialisation status
Dematerialisation requests were confirmed to the depositories by the RTA.
Securities dematerialised have been listed on the exchanges where the earlier issues are listed.
Physical certificates for dematerialisation were mutilated and cancelled; depository's name substituted as registered owner within 30 days.
1 Jul 2026 1 filing
Price/Volume movement update
Period covered: June 19–30, 2026, with notable price and volume action.
30-Jun-26: 7,408 trades; 344,800 deliverable qty; 40.10% deliverable; high price 238.60.
29-Jun-26: 909 trades; 23,792 deliverable qty; 45.72% deliverable; high price 207.50.
25-Jun-26: 1,509 trades; 54,854 deliverable qty; 48.41% deliverable; high price 212.50.
24-Jun-26: 1,997 trades; 53,757 deliverable qty; 35.54% deliverable; high price 211.30.
23-Jun-26: 2,406 trades; 93,254 deliverable qty; 52.54% deliverable; high price 218.80.
22-Jun-26: 4,660 trades; 134,863 deliverable qty; 40.18% deliverable; high price 220.75.
19-Jun-26: 4,880 trades; 127,113 deliverable qty; 36.95% deliverable; high price 196.00.
Compliance note: Reiterates adherence to SEBI LODR Regulation 30 and timely disclosures.
Action note: Requests stock exchange to note movements and consider appropriate action.